Author:
Waterhouse David M.,Espirito Janet L.,Chioda Marc D.,Baidoo Bismark,Mardekian Jack,Robert Nicholas J.,Masters Elizabeth T.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. https://doi.org/10.3322/caac.21551.
2. Petersen I. The morphological and molecular diagnosis of lung cancer. Dtsch Arztebl Int. 2011;108(31–32):525–31. https://doi.org/10.3238/arztebl.2011.0525.
3. PDQ® Adult Treatment Editorial Board. PDQ non-small cell lung cancer treatment. Bethesda, MD: National Cancer Institute. 2019. https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq. Accessed 24 May 2019 (PMID: 26389304).
4. Du X, Shao Y, Qin H-F, Tai Y-H, Gao H-J. ALK-rearrangement in non-small-cell lung cancer (NSCLC). Thorac Cancer. 2018;9:423–30. https://doi.org/10.1111/1759-7714.12613.
5. Lantuejoul S, Rouquette I, Blons H, et al. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas. Eur Respir J. 2015;46:207–18. https://doi.org/10.1183/09031936.00119914.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献